A detailed history of Exchange Traded Concepts, LLC transactions in Altimmune, Inc. stock. As of the latest transaction made, Exchange Traded Concepts, LLC holds 216,761 shares of ALT stock, worth $1.64 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
216,761
Previous 124,263 74.44%
Holding current value
$1.64 Million
Previous $826,000 61.02%
% of portfolio
0.03%
Previous 0.02%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 10, 2024

BUY
$5.5 - $8.1 $508,739 - $749,233
92,498 Added 74.44%
216,761 $1.33 Million
Q2 2024

Aug 13, 2024

BUY
$5.91 - $10.23 $734,394 - $1.27 Million
124,263 New
124,263 $826,000

Others Institutions Holding ALT

About Altimmune, Inc.


  • Ticker ALT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 49,025,300
  • Market Cap $370M
  • Description
  • Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide (proposed INN, formerly known as ALT-801), is a GLP-1/glucagon dual receptor agonist that is in Phase 1b trial for the treatment of obesity and non-alcoholic steatohepatit...
More about ALT
Track This Portfolio

Track Exchange Traded Concepts, LLC Portfolio

Follow Exchange Traded Concepts, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exchange Traded Concepts, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Exchange Traded Concepts, LLC with notifications on news.